BS

Byregowda Santhekopal Nalini

Active Director Additional Director DIN 10743977
DIN 10743977 First appointment Aug 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Byregowda Santhekopal Nalini

Data last updated:

Byregowda Santhekopal Nalini is an Additional Director at Morel Bio Science Private Limited (since 2024). The company operates in Paper.

DIN 10743977
Primary Designation Additional Director
Industry Paper
First Appointment 16 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Morel Bio Science Private Limited U21001KA2024PTC190697
Additional Director16 Aug 20242024Active

Board colleagues of Byregowda Santhekopal Nalini

Directorship timeline

Open interactive timeline →
Morel Bio Science Private Limited
Premium access

Shareholding and investment profile for Byregowda Santhekopal Nalini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Byregowda Santhekopal Nalini

Byregowda Santhekopal Nalini currently holds 1 directorship: Morel Bio Science Private Limited (Additional Director, since 16 Aug 2024).

Byregowda Santhekopal Nalini was first appointed on 16 Aug 2024 as Additional Director at Morel Bio Science Private Limited.

The current boards of Byregowda Santhekopal Nalini's companies include Sangeeta Verma (Morel Bio Science Private Limited), Sunil Verma (Morel Bio Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available